Try it
Pharmacology · Chemotherapy: gemcitabine toxicity
Sample itemA 62-year-old man with pancreatic adenocarcinoma receives several cycles of chemotherapy and develops microangiopathic haemolytic anaemia, thrombocytopenia and renal failure. Which drug is the most likely cause?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Gemcitabine
Gemcitabine, a deoxycytidine analogue and standard drug in pancreatic cancer, can cause thrombotic microangiopathy with haemolytic uraemic syndrome. It also causes myelosuppression and flu-like symptoms. Mitomycin is another cause of this syndrome.
Option by option
A. Gemcitabine (correct)
Correct. Gemcitabine can cause haemolytic uraemic syndrome.
B. Vincristine
Vincristine causes neuropathy and constipation rather than haemolytic uraemia.
C. Methotrexate
Methotrexate causes mucositis, myelosuppression and renal tubular crystal injury.
D. Cytarabine
Cytarabine causes myelosuppression and cerebellar toxicity.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?